SHSamaneh Hatami

Samaneh Hatami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samaneh Hatami has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A comparison between the total and best regions of trabecular bone scores and evaluating the added value of combining the trabecular bone scores with bone-mineral density

    by Alireza Rajaei, Pooneh Dehghan, Samaneh Hatami

    Introduction: Bone mineral density (BMD) and trabecular bone score (TBS) are recognized as two indexes for diagnosis of osteoporosis. Objectives: The present study assesses the TBS performance as an alternative test for BMD. Patients and Methods: A retrospective descriptive study conducted on 2,106 patients were referred to two central hospitals; Resalat and Loghman in Tehran, Iran. Necessary data have been collected for the analysis process, including age, gender, body mass index, and L1-L4 TBS. Results: Four-hundred eligible patients were considered for our analysis process. Among these patients, about 13.8 and 86.3% were men and women with mean ages of 54.04 ± 10.92 and 53.83 ± 10.16 years, respectively (P=0.88). Our study showed a statistically significant difference between the mean TBS of all regions in patients (P=0.001), while this value was dependent on the gender and age of patients. The mean TBS of all regions in women younger than 50 years was significantly higher than those older than 50 years (P<0.001). Moreover, a statistically significant difference was observed between the means of the best regional TBS in all study groups (P<0.001). This study showed the lumbar spine TBS had a negative correlation with body mass index in women, while this correlation was not significant in men. Conclusion: Trabecular bone score can be conducted as a complementary index along with BMD, it can be employed independently as an appropriate indicator for osteoporosis.


  • Open Access

    Multiple long bone fractures in a man with pycnodysostosis; a case report

    by Mozhdeh Zabihiyeganeh, Milad Haji Agha Bozorgi, Samaneh Hatami

    Pycnodysostosis is a rare genetic disease that is diagnosed in childhood however in very rare conditions, maybe diagnosed in adulthood. It is presented by dental malformation, short stature and short extremities, multiple fractures with low-pressure forces, and some other manifestations. In this case report, we present a patient with typical pycnodysostosis manifestations including a hard palatine groove, poor hygiene oral situation, dental malformation, and several fractures with a low threshold pressure.


  • Open Access

    The prevalence of COVID-19 in patients with rheumatoid arthritis, multiple sclerosis, or systemic lupus erythematosus receiving biologic disease-modifying antirheumatic drugs

    by Arman Ahmadzadeh, Faraneh Farsad, Mohammad Mehdi Emam, Alireza Rajaei, Samaneh Hatami, Latif Gachkar

    Introduction: The coronavirus disease (COVID-19) became a global pandemic in 2019. Some studies have shown that the virus can cause a higher mortality in people with weakened immune systems, such as the elderly, those taking immunosuppressive drugs, and those with underlying disorders, than in the general population. Objectives: The aim of this study was to evaluate the prevalence of COVID-19 in patients with rheumatic disorders who received biologic disease-modifying antirheumatic drugs (DMARDs). The effect of precautionary self-isolation in these patients was also determined. Patients and Methods: This descriptive study involved 200 patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and multiple sclerosis (MS) who were treated with biologic DMARDs. Patients with symptoms of the coronavirus infection were invited to have a COVID-19 test that involved a COVID-19 IgG antibody test or a polymerase chain reaction (PCR) test (i.e., nasal swab). Additionally, patients were asked about their precautionary self-isolation status during this period. Results: The mean age of the patients was 51.29 years ± 13.38 years. The ratio of males to females was 27 to 173. Of the 200 patients included in the study, 156 (78%) had RA, 10 (5%) had SLE, and 34 (17%) had MS. Seventy-five percent of the patients used rituximab. Ten patients (5%) were symptomatic of COVID-19, although only four patients had a definitive diagnosis of the disease. All patients who were symptomatic of COVID-19 took rituximab. Ten percent of patients who did not observe the precautionary self-isolation period were diagnosed with COVID-19. Conclusion: Patients who receive biologic DMARDs have a lower risk of developing COVID-19 and a lower risk of mortality from the disease than the general population.